Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction

Area of Science:

• Cardiovascular Physiology
• Molecular Biology
• Genetics

Background:

• Environmental factors for hypertension and cardiovascular disease are known, but genetic and signaling pathways remain largely uncharacterized.
• Few genes linked to cardiovascular pathologies have been identified despite extensive research.

Purpose of the Study:

• To identify novel genetic factors regulating cardiovascular homeostasis.
• To elucidate the role of Vav3 in cardiovascular and sympathetic nervous system (SNS) regulation.

Main Methods:

• Generated and analyzed Vav3-deficient mice.
• Assessed cardiovascular parameters including heart rate, blood pressure, and organ remodeling.
• Investigated sympathetic neuron activity and hormonal pathways (catecholamines, renin-angiotensin system).
• Utilized pharmacological interventions to confirm causal relationships.

Main Results:

• Vav3-deficient mice displayed tachycardia, systemic arterial hypertension, and significant cardiovascular remodeling.
• These mice exhibited sympathetic neuron hyperactivity from birth, leading to elevated catecholamines.
• Activation of the renin-angiotensin system and hormonal imbalances contributed to progressive loss of cardiovascular and renal homeostasis.
• Pharmacological studies validated the role of SNS and renin-angiotensin system in the observed phenotype.

Conclusions:

• Vav3 is essential for maintaining cardiovascular system homeostasis.
• Vav3 plays a critical role in regulating the sympathetic nervous system.
• The identified Vav3 signaling pathway offers insights into human diseases with tachycardia and sympathetic hyperactivity of unknown origin.